EPAS1 and nonpapillary renal cell carcinoma: PAG1 attracted our attention because it had been reported to be overexpressed in clear cell renal cell carcinoma (ccRCC) which is frequently associated with loss of VHL function and constitutive HIF-2α overexpression (28).